This inventor holds 2 USPTO granted patents. Top assignees: Toyo Engineering Corporation, Yoshitomi Pharmaceutical Industries, Ltd., Other. Active years: 1981-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1981-1989
Title: Yutaka Yamaguchi: Innovator in Medical and Industrial Solutions
Introduction
Yutaka Yamaguchi is a notable inventor based in Chiba, Japan. He has made significant contributions to both medical and industrial fields through his innovative patents. With a total of 2 patents, Yamaguchi's work showcases his versatility and expertise.
Latest Patents
Yamaguchi's latest patents include a human monoclonal antibody to lung carcinoma and a transportable bed for industrial equipment. The human monoclonal antibody is designed for use as a diagnostic agent in serological diagnosis, radioimaging of lung tumors, or as a therapeutic agent. This innovation is particularly significant for its application in treating lung squamous and adenocarcinomas. The transportable bed serves as a support for industrial equipment and machinery during erection, transportation, and installation. It features a horizontal floor for mounting equipment, a central strengthening structure with spaced-apart girders, and side supports for added stability.
Career Highlights
Throughout his career, Yutaka Yamaguchi has worked with Yoshitomi Pharmaceutical Industries, Ltd., where he contributed to advancements in pharmaceutical technologies. His work has had a lasting impact on both the medical and industrial sectors.
Collaborations
Yamaguchi has collaborated with notable individuals such as Masaru Taniguchi and Hiroaki Saito, further enhancing his contributions to innovation.
Conclusion
Yutaka Yamaguchi's inventive spirit and dedication to improving medical and industrial solutions are evident in his patents. His work continues to influence these fields, showcasing the importance of innovation in addressing complex challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile